DeepMatter Group Company
DeepMatter Group provides medical research and development services.
Technology:
Analytics, Biotechnology, Pharmaceutical, Product Research, Software
Industry:
AI in Pharma, Early Drug Development
Headquarters:
Glasgow, Glasgow City, United Kingdom
Founded Date:
2015-01-01
Employees Number:
11-50
Funding Status:
IPO
Acquisitions Number:
2
Investors Number:
1
Estimated Revenue:
$1M to $10M
Last Funding Date:
2019-03-18
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership